Price movement over the last 24 hours
Aegon Ltd. vs Inovio Pharmaceuticals Inc — how do they compare? Aegon Ltd. trades at $8.73 (market cap $12.98B), while Inovio Pharmaceuticals Inc trades at $1.22 (market cap $99.55M). The key difference: Aegon Ltd. is far larger — about 130.4× Inovio Pharmaceuticals Inc's market cap, and Aegon Ltd. pays a 5.3% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AEG | INO | |
|---|---|---|
Market Cap | $12.98B | $99.55M |
Sector | Financials | Health |
52-Week High | $8.79 | $2.87 |
52-Week Low | $6.79 | $1.05 |
Enterprise Value | $14.11B | $70.56M |
Dividend Yield | 5.3% | — |
Trailing returns across standard periods
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →